Sullivan Christopher Ryan
Chief Financial Officer at AVTX
- Sold, on record
- $3.7M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Sep 16, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AVTXAvalo Therapeutics, Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AVTXRoutineApr 30, 2026 2026
Sold 16,915 shares at $13.16 ($223k)
Sullivan Christopher Ryan, Chief Financial Officer
10b5-1 planSold 97.6% of holdings ($228k position)423 shares leftFiling
- 2 Form 144 notice AVTXNoticeMay 6, 2026 +6 days
Filed to sell 47,000 shares ($764k)
Sullivan Christopher Ryan, Officer
10b5-1 planFiling
- 3 Form 4 sale AVTXRoutineMay 6, 2026 same day
Sold 47,000 shares at $20.18 ($949k)
Sullivan Christopher Ryan, Chief Financial Officer
10b5-1 planSold 99.1% of holdings ($957k position)423 shares leftFiling
- 4 Form 144 notice AVTXNoticeMay 7, 2026 +1 day
Filed to sell 18,606 shares ($406k)
Sullivan Christopher Ryan, Officer
10b5-1 plan1.1x usual sizeFiling
- 5 Form 4 sale AVTXRoutineMay 7, 2026 same day
Sold 18,606 shares at $24.12 ($449k)
Sullivan Christopher Ryan, Chief Financial Officer
10b5-1 planSold 97.8% of holdings ($459k position)423 shares left1.1x usual sizeFiling
- 6 Form 4 sale AVTXUnusualAug 18, 2026 +103 days
Sold 72,725 shares at $19.94 ($1.5M)
Sullivan Christopher Ryan, Chief Financial Officer
10b5-1 planSold 64.6% of holdings ($2.2M position)39,900 shares left4.1x usual sizeFiling
- 7 Form 4 sale AVTXRoutineSep 10, 2026 +23 days
Sold 10,185 shares at $17.62 ($179k)
Sullivan Christopher Ryan, Chief Financial Officer
10b5-1 planSold 20.3% of holdings ($882k position)39,900 shares left0.5x usual sizeFiling
- 8 Form 4 sale AVTXRoutineSep 16, 2026 +6 days
Sold 12,394 shares at $16.33 ($202k)
Sullivan Christopher Ryan, Chief Financial Officer
10b5-1 planSold 23.7% of holdings ($854k position)39,900 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sep 18, 2026 | AVTX | Chief Financial Officer | Form 4 sale | 12,394 | $202k | 23.7% | Routine | SEC |
| Sep 10, 2026 | Sep 11, 2026 | AVTX | Chief Financial Officer | Form 4 sale | 10,185 | $179k | 20.3% | Routine | SEC |
| Aug 18, 2026 | Aug 19, 2026 | AVTX | Chief Financial Officer | Form 4 sale | 72,725 | $1.5M | 64.6% | Unusual | SEC |
| May 7, 2026 | May 11, 2026 | AVTX | Chief Financial Officer | Form 4 sale | 18,606 | $449k | 97.8% | Routine | SEC |
| May 7, 2026 | May 7, 2026 | AVTX | Officer | Form 144 notice | 18,606 | $406k | Notice | SEC | |
| May 6, 2026 | May 7, 2026 | AVTX | Chief Financial Officer | Form 4 sale | 47,000 | $949k | 99.1% | Routine | SEC |
| May 6, 2026 | May 6, 2026 | AVTX | Officer | Form 144 notice | 47,000 | $764k | Notice | SEC | |
| Apr 30, 2026 | May 1, 2026 | AVTX | Chief Financial Officer | Form 4 sale | 16,915 | $223k | 97.6% | Routine | SEC |
| Apr 29, 2026 | Apr 29, 2026 | AVTX | Officer | Form 144 notice | 16,915 | $218k | Notice | SEC | |
| Apr 2, 2026 | Apr 3, 2026 | AVTX | Chief Financial Officer | Form 4 sale | 15,959 | $271k | 47.9% | Routine | SEC |
| Apr 1, 2026 | Apr 1, 2026 | AVTX | Officer | Form 144 notice | 15,959 | $238k | Notice | SEC |